Actively Recruiting
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-08-26
400
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary objective: The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.
CONDITIONS
Official Title
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged >18 years, both sexes
- Signed written informed consent
You will not qualify if you...
- Patients diagnosed with psoriasis, atopic dermatitis, vitiligo, or alopecia areata
- Patients with first-degree relatives diagnosed with psoriasis, atopic dermatitis, vitiligo, or alopecia areata
- Individuals with professional or personal knowledge of these diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia
Roma, Italia, Italy, 00168
Actively Recruiting
Research Team
C
Caldarola
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here